Existing antibiotics underpin much of modern medicine but are rapidly losing their ability to treat many deadly infections, according to the Centers for Disease Control and Prevention. Yet even as more strains of drug-resistant bacteria emerge, the introduction of new antibiotics has slowed down. Congress should enact a proposed new regulatory pathway that will help spur the investment that can bring new lifesaving treatments to the public.
The need is apparent. The CDC has estimated that each year at least two million Americans…